Vivek J. Kadambi

2.2k total citations
41 papers, 1.7k citations indexed

About

Vivek J. Kadambi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Vivek J. Kadambi has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 6 papers in Immunology. Recurrent topics in Vivek J. Kadambi's work include Cardiac electrophysiology and arrhythmias (15 papers), Ion channel regulation and function (11 papers) and Cardiomyopathy and Myosin Studies (7 papers). Vivek J. Kadambi is often cited by papers focused on Cardiac electrophysiology and arrhythmias (15 papers), Ion channel regulation and function (11 papers) and Cardiomyopathy and Myosin Studies (7 papers). Vivek J. Kadambi collaborates with scholars based in United States, Germany and Belgium. Vivek J. Kadambi's co-authors include Evangelia G. Kranias, Brian D. Hoit, Richard A. Walsh, Sathivel Ponniah, J HARRER, G W Dorn, Gerald W. Dorn, Yoji Sato, Guoxiang Chu and Donald G. Ferguson and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Vivek J. Kadambi

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivek J. Kadambi United States 21 1.1k 805 168 161 145 41 1.7k
Yunbo Ke United States 26 1.3k 1.2× 581 0.7× 160 1.0× 66 0.4× 139 1.0× 71 1.7k
Gabriel Birrane United States 23 1.0k 1.0× 278 0.3× 105 0.6× 172 1.1× 129 0.9× 45 1.6k
Samuel E. George United States 20 818 0.8× 329 0.4× 102 0.6× 155 1.0× 128 0.9× 35 1.5k
Sasha A. Singh United States 24 1.4k 1.3× 406 0.5× 357 2.1× 183 1.1× 312 2.2× 83 2.5k
K S Arnold United States 22 1.1k 1.0× 241 0.3× 272 1.6× 184 1.1× 70 0.5× 32 2.3k
Robert S. Haworth United Kingdom 27 1.3k 1.2× 801 1.0× 54 0.3× 54 0.3× 99 0.7× 37 1.8k
Joan Carles Ferreres Spain 20 786 0.7× 203 0.3× 73 0.4× 84 0.5× 174 1.2× 51 1.3k
Ronald J. Holewinski United States 22 833 0.8× 437 0.5× 117 0.7× 41 0.3× 118 0.8× 41 1.3k
D R van der Westhuyzen South Africa 28 1.3k 1.2× 258 0.3× 221 1.3× 215 1.3× 230 1.6× 47 2.6k
L Chao United States 23 544 0.5× 334 0.4× 149 0.9× 153 1.0× 66 0.5× 57 1.6k

Countries citing papers authored by Vivek J. Kadambi

Since Specialization
Citations

This map shows the geographic impact of Vivek J. Kadambi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek J. Kadambi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek J. Kadambi more than expected).

Fields of papers citing papers by Vivek J. Kadambi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek J. Kadambi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek J. Kadambi. The network helps show where Vivek J. Kadambi may publish in the future.

Co-authorship network of co-authors of Vivek J. Kadambi

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek J. Kadambi. A scholar is included among the top collaborators of Vivek J. Kadambi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek J. Kadambi. Vivek J. Kadambi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schöffski, Patrick, Michael C. Heinrich, Jonathan C. Trent, et al.. (2024). StrateGIST 1: A first-in-human (FIH), phase 1 study of IDRX-42 in patients with metastatic gastrointestinal stromal tumors resistant to prior treatment with tyrosine kinase inhibitors (TKIs).. Journal of Clinical Oncology. 42(16_suppl). 11501–11501. 5 indexed citations
2.
Valentin, Jean‐Pierre, Jean‐Michel Guillon, Stephen Jenkinson, et al.. (2018). In vitro secondary pharmacological profiling: An IQ-DruSafe industry survey on current practices. Journal of Pharmacological and Toxicological Methods. 93. 7–14. 24 indexed citations
3.
4.
Fedyk, Eric R., Tim Wyant, Lili Yang, et al.. (2012). Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates. Inflammatory Bowel Diseases. 18(11). 2107–2119. 114 indexed citations
5.
Alden, Carl L., Andrew M. Lynn, Daniel Morton, et al.. (2011). A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk. Veterinary Pathology. 48(3). 772–784. 35 indexed citations
6.
Kadambi, Vivek J., et al.. (2011). Antibody drug conjugates — Trojan horses in the war on cancer. Journal of Pharmacological and Toxicological Methods. 64(3). 207–212. 54 indexed citations
7.
Fedyk, Eric R., et al.. (2011). The gastrointestinal-selective biologic vedolizumab does not impair immune surveillance of the central nervous system in non-human primates.. Inflammatory Bowel Diseases. 17(suppl_1). S4–S5. 7 indexed citations
8.
Maziasz, Timothy J., Vivek J. Kadambi, Lee Silverman, Eric R. Fedyk, & Carl L. Alden. (2010). Predictive Toxicology Approaches for Small Molecule Oncology Drugs. Toxicologic Pathology. 38(1). 148–164. 10 indexed citations
9.
Csizmadia, Vilmos, Eva Csizmadia, Lee Silverman, et al.. (2010). Effect of Proteasome Inhibitors With Different Chemical Structures on the Ubiquitin–Proteasome System In Vitro. Veterinary Pathology. 47(2). 358–367. 16 indexed citations
10.
Parikh, A., Eric R. Fedyk, Vivek J. Kadambi, et al.. (2009). P130 - Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to α 4β 7 integrin. Journal of Crohn s and Colitis. 3(1). S62–S62. 1 indexed citations
11.
Blackburn, Christopher, Matthew J. LaMarche, James A. Brown, et al.. (2006). Identification and characterization of amino-piperidinequinolones and quinazolinones as MCHr1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(10). 2621–2627. 21 indexed citations
12.
Christe, Michael E., Najia Jin, Xushan Wang, et al.. (2004). Transgenic mice with cardiac-specific over-expression of MLK7 have increased mortality when exposed to chronic β-adrenergic stimulation. Journal of Molecular and Cellular Cardiology. 37(3). 705–715. 11 indexed citations
13.
Sasseville, Vito G., Joan H. Lane, Vivek J. Kadambi, et al.. (2004). Testing paradigm for prediction of development-limiting barriers and human drug toxicity. Chemico-Biological Interactions. 150(1). 9–25. 13 indexed citations
14.
Hoit, Brian D., et al.. (1999). Influence of Transgenic Overexpression of Phospholamban on Postextrasystolic Potentiation. Journal of Molecular and Cellular Cardiology. 31(11). 2007–2015. 19 indexed citations
15.
Luo, Wusheng, et al.. (1998). Transgenic Approaches to Define the Functional Role of Dual Site Phospholamban Phosphorylation. Journal of Biological Chemistry. 273(8). 4734–4739. 89 indexed citations
16.
Kadambi, Vivek J. & Evangelia G. Kranias. (1998). Genetically engineered mice: Model systems for left ventricular failure. Journal of Cardiac Failure. 4(4). 349–361. 17 indexed citations
17.
Chu, Guoxiang, Li Li, Yoji Sato, et al.. (1998). Pentameric Assembly of Phospholamban Facilitates Inhibition of Cardiac Function in Vivo. Journal of Biological Chemistry. 273(50). 33674–33680. 39 indexed citations
18.
Kadambi, Vivek J. & Evangelia G. Kranias. (1997). Phospholamban: A Protein Coming of Age. Biochemical and Biophysical Research Communications. 239(1). 1–5. 53 indexed citations
19.
Haghighi, Kobra, Vivek J. Kadambi, Wusheng Luo, et al.. (1997). In vitro and in vivo promoter analyses of the mouse phospholamban gene. Gene. 203(2). 199–207. 16 indexed citations
20.
Kadambi, Vivek J., Sathivel Ponniah, J HARRER, et al.. (1996). Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.. Journal of Clinical Investigation. 97(2). 533–539. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunbo Ke Breakdown of academic impact, for papers by Gabriel Birrane Breakdown of academic impact, for papers by Samuel E. George Breakdown of academic impact, for papers by Sasha A. Singh Breakdown of academic impact, for papers by K S Arnold Breakdown of academic impact, for papers by Robert S. Haworth Breakdown of academic impact, for papers by Joan Carles Ferreres Breakdown of academic impact, for papers by Ronald J. Holewinski Breakdown of academic impact, for papers by D R van der Westhuyzen Breakdown of academic impact, for papers by L Chao
Rankless by CCL
2026